Christopher R. Anderton
Pacific Northwest National Laboratory
Candidate Statement
Some of the most important work in a scientific society happens out of view: keeping accurate records, maintaining clear governance, and running fair Board elections. Through my service on ASMS committees, as President of the International Mass Spectrometry Imaging Society (IMSIS)–Americas, and as a liaison during the merger that created IMSIS-Global, I have seen how much this work underpins a community’s trust. I would be honored to serve as Secretary, documenting the Board’s decisions clearly, keeping our bylaws and policies current, monitoring the online balloting for the annual Board election, and coordinating the selection of ASMS’s highest honors with rigor and integrity.
Christopher R. Anderton, B.S. in Chemistry (University of Colorado, Colorado Springs, with David J. Weiss), Ph.D. in Analytical Chemistry (University of Illinois Urbana-Champaign, with Mary L. Kraft), NRC Postdoctoral Associate (National Institute of Standards and Technology, with Anne L. Plant), Postdoctoral Research Associate (Pacific Northwest National Laboratory, with Ljiljana Paša-Tolić). Dr. Anderton is currently a Chief Scientist and Mass Spectrometry Imaging Capability Lead at the Environmental Molecular Sciences Laboratory (EMSL), a U.S. Department of Energy user facility at PNNL in Richland, Washington, where he also leads the Microbial Biotechnology Campaign. From 2025 to 2026, he served as EMSL’s Interim Chief Science Officer.
Dr. Anderton’s research develops multimodal mass spectrometry imaging and spatial omics approaches to map a variety of biomolecules in human tissues, plants, and environmental microbiomes. His approaches leverage multiple ionization techniques (e.g., MALDI, SIMS, LAESI, and nano-DESI) for MS imaging coupled with ultrahigh-resolution FTICR and ion mobility MS. He currently leads PNNL’s efforts in the NIH Kidney Precision Medicine Project as well as several DOE-funded projects, has coauthored more than 110 peer-reviewed publications, and serves on the editorial board of mSystems.
An ASMS member since 2014, Dr. Anderton has served on the Publications Committee (2019–2021), where he created the ASMS Twitter account, and on the Asilomar and Small Conference Committees (2023–2026). He co-organized the annual conference workshop on advances in 2D and 3D mass spectrometry from 2017 to 2019 and co-chaired a pre-Asilomar workshop on imaging data analysis in 2019. He has also reviewed regularly for JASMS since 2014. Beyond ASMS, he is President of IMSIS–Americas (formerly the Imaging Mass Spectrometry Society) and Vice President of the IMSIS-Global, and he chaired the Plant Cell Atlas Metabolomics Committee.